Limelight Bio

Limelight is a privately held, multi-platform, multi-disease biopharmaceutical company headquartered in Philadelphia, PA and Cambridge, MA. Limelight Bio is pioneering new therapies that break down barriers of current genetic medicine to bring hope to as many patients and families as possible. Since 2017, Limelight has been developing proprietary technologies, advanced targets, and leading drug candidates designed to overcome key limitations of current gene therapy and gene editing approaches.

网站

https://www.limelightbio.org

Limelight Bio的外部链接

所属行业

生物技术研究

规模

11-50 人

总部

Philadelphia，Pennsylvania

类型

私人持股

创立

2016